Materialise NV

NasdaqGS MTLS

Materialise NV Debt to Equity Ratio for the year ending December 31, 2023: 0.27

Materialise NV Debt to Equity Ratio is 0.27 for the year ending December 31, 2023, a -23.06% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Materialise NV Debt to Equity Ratio for the year ending December 31, 2022 was 0.35, a -17.00% change year over year.
  • Materialise NV Debt to Equity Ratio for the year ending December 31, 2021 was 0.43, a -50.73% change year over year.
  • Materialise NV Debt to Equity Ratio for the year ending December 31, 2020 was 0.86, a -5.66% change year over year.
  • Materialise NV Debt to Equity Ratio for the year ending December 31, 2019 was 0.92, a 17.56% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
NasdaqGS: MTLS

Materialise NV

CEO Ms. Brigitte de Vet-Veithen
IPO Date June 25, 2014
Location Belgium
Headquarters Technologielaan 15
Employees 2,437
Sector Technology
Industries
Description

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Similar companies

CWAN

Clearwater Analytics Holdings, Inc.

USD 28.67

0.95%

ADEA

Adeia Inc.

USD 12.62

1.12%

ONTF

ON24, Inc.

USD 7.01

1.74%

EXFY

Expensify, Inc.

USD 3.82

-0.26%

VTEX

VTEX

USD 6.67

-1.48%

LAW

CS Disco, Inc.

USD 5.23

2.15%

ENFN

Enfusion, Inc.

USD 11.18

-0.09%

CCRD

CoreCard Corporation

USD 23.07

-1.79%

MLNK

MeridianLink, Inc.

USD 19.26

0.31%

StockViz Staff

February 6, 2025

Any question? Send us an email